Researchers at Israel’s Ben-Gurion University are developing a new, single-dose fertility treatment based on a new telomerase-activating compound, which can improve both male and female fertility. It can also help protect the fertility of cancer patients undergoing radiation therapy.
Improved fertility treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.